EcoDrugPlus

Calcium Voltage-Gated Channel Subunit Alpha1 I

Ensembl ID : ENSOKIG00005047375
Gene Symbol: CACNA1I
1 Cross references
196 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSOKIG00005008725
Gene Symbol: CNR1
3 Cross references
129 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSOKIG00005002485
Gene Symbol: CNR1
1 Cross references
144 Possible Orthologues:

Cannabinoid Receptor 1

Ensembl ID : ENSOKIG00005002462
Gene Symbol: CNR1
3 Cross references
128 Possible Orthologues:

Cannabinoid Receptor 2

Ensembl ID : ENSOKIG00005017757
Gene Symbol: LOC109909834
3 Cross references
185 Possible Orthologues:

Cannabinoid Receptor 2-Like

Ensembl ID : ENSOKIG00005013302
Gene Symbol: LOC109901760
3 Cross references
184 Possible Orthologues:

Cannabinoid Receptor Type 1a

Ensembl ID : ENSOKIG00005006089
Gene Symbol: LOC109866266
3 Cross references
144 Possible Orthologues:

Carbonic Anhydrase 12

Ensembl ID : ENSOKIG00005014986
Gene Symbol: CA12
1 Cross references
208 Possible Orthologues:

Carbonic Anhydrase 14-Like

Ensembl ID : ENSOKIG00005040259
Gene Symbol: LOC109883760
2 Cross references
202 Possible Orthologues:

Carbonic Anhydrase 4

Ensembl ID : ENSOKIG00005027311
Gene Symbol: LOC109909110
2 Cross references
190 Possible Orthologues:

Carbonic Anhydrase 4

Ensembl ID : ENSOKIG00005009773
Gene Symbol: LOC109893035
3 Cross references
206 Possible Orthologues:

Carbonic Anhydrase 4-Like

Ensembl ID : ENSOKIG00005037012
Gene Symbol: LOC109873354
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).